Repeated heart and blood checks after a pulmonary embolism to understand early recovery
Follows adults with pulmonary embolism using repeated tests in the first 48 hours.
Key facts
- Who runs it
- Sahlgrenska University Hospital
- Where
- Sweden3 sites in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Repeated Examinations for Typing Pulmonary Embolism
- Status
- Recruiting
- People taking part
- 400 people, planned
- Started
- 1 Apr 2026
- Expected to end
- 1 Jan 2032
- Type of study
- Observational, 2 groups
- Record updated
- 13 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults diagnosed with, or followed as out-patients for, a blood clot in the lungs (pulmonary embolism, PE) at Sahlgrenska University Hospital.
- Age
- 18 years and older
- Sex
- All sexes
- Disease stage
- Cohort A: intermediate-high risk PE, within 48 hours of diagnosis. Cohort B: PE of any risk class, scheduled for follow-up at Sahlgrenska University Hospital.
Main reasons for not taking part
- Cohort A: low risk, intermediate-low risk or high risk PE
- Cohort A: more than 48 hours since PE diagnosis
- Cohort A: expected to be unable to follow the study plan (for example dementia)
- Cohort B: not living in the area served by Sahlgrenska University Hospital
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Adult patients (≥ 18 years old) who is diagnosed with, or followed as out-patients for, PE at Sahlgrenska University Hospital
- Written informed consent
Who cannot take part
- Expected inability to comply with the protocol (e.g. dementia); Exclusion Criterium from Cohort B:
- Low risk, intermediate-low risk or high risk PE*
- >48 hours since PE diagnosis
- Not geographically belonging to Sahlgrenska University Hospital; *If biomarkers (and/or echocardiography) are not available in hemodynamically stable patients, RV/LV-ratio >1 will be considered as preliminary intermediate-high risk. If biomarkers later fall out negative, the patient will be considered as intermediate-low risk and will be moved to Cohort B
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
PURPOSE
Read full original descriptionShow less
The two related purposes of the RE-TyPE study are:
1. To improve understanding of the early clinical course of intermediate-high risk pulmonary embolism and its association with outcome and 2. To establish a platform for longitudinal follow-up for all pulmonary embolism at Sahlgrenska University Hospital
HYPOTHESES
1. The dynamic pattern of change, evaluated thorough repeated measures of biomarkers, electrocardiography and echocardiography during the first 48 hours after pulmonary embolism, better predicts outcome than static measurements currently used to predict outcome 2. Establishment of a platform for longitudinal follow-up will improve quality of care and outcome for patients with pulmonary embolism at Sahlgrenska University Hospital
The 2 groups in the trial
- Cohort A
Intermediate-high risk pulmonary embolism admitted to Sahlgrenska University Hospital - prospective phenotyping thorugh serial investigations day 0, 1, 2 30 and 90.
- Cohort B
All risk classes of pulmonary embolism scheduled for follow-up at Sahlgrenska University Hospital - retrospective and prospective phenotyping at day 0, 90 (inclusion) and \>12 months (Cohorts overlap since all patients in Cohort A who geographically belong to Sahlgrenska University Hosptial are also part of Cohort B)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Repeated Examinations for Typing Pulmonary Embolism (RE-TyPE)
- Plain-language title
- Repeated heart and blood checks after a pulmonary embolism to understand early recoveryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 13 October 2026